| Literature DB >> 35762249 |
Ayal A Aizer1, Nayan Lamba1,2, Manmeet S Ahluwalia3, Kenneth Aldape4, Adrienne Boire5, Priscilla K Brastianos6, Paul D Brown7, D Ross Camidge8, Veronica L Chiang9, Michael A Davies10, Leland S Hu11, Raymond Y Huang12, Timothy Kaufmann13, Priya Kumthekar14, Keng Lam15, Eudocia Q Lee8, Nancy U Lin8, Minesh Mehta16, Michael Parsons17, David A Reardon8, Jason Sheehan18, Riccardo Soffietti19, Hussein Tawbi10, Michael Weller20, Patrick Y Wen8.
Abstract
Brain metastases occur commonly in patients with advanced solid malignancies. Yet, less is known about brain metastases than cancer-related entities of similar incidence. Advances in oncologic care have heightened the importance of intracranial management. Here, in this consensus review supported by the Society for Neuro-Oncology (SNO), we review the landscape of brain metastases with particular attention to management approaches and ongoing efforts with potential to shape future paradigms of care. Each coauthor carried an area of expertise within the field of brain metastases and initially composed, edited, or reviewed their specific subsection of interest. After each subsection was accordingly written, multiple drafts of the manuscript were circulated to the entire list of authors for group discussion and feedback. The hope is that the these consensus guidelines will accelerate progress in the understanding and management of patients with brain metastases, and highlight key areas in need of further exploration that will lead to dedicated trials and other research investigations designed to advance the field.Entities:
Keywords: brain metastases; consensus; expert; guidelines; recommendations; treatment
Mesh:
Year: 2022 PMID: 35762249 PMCID: PMC9527527 DOI: 10.1093/neuonc/noac118
Source DB: PubMed Journal: Neuro Oncol ISSN: 1522-8517 Impact factor: 13.029